Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
KRW BioReg Solutions is a UK-based regulatory and technical consulting company focused on medicinal product development in biotech and pharma rather than a drug developer with its own therapeutic pipeline. The company provides strategic regulatory advice across chemistry, manufacturing and controls, analytical development, manufacturing and supply, lifecycle management, and non-clinical and clinical development. Its stated focus includes biological products, biosimilars, combination products, blood products, innovator medicines, and repurposed medicines. KRW BioReg Solutions is owned and managed by Keith Watson, a former regulator with experience at the MHRA and in biologics-focused regulatory functions. The company appears to operate as a private, active specialist consultancy serving advanced therapy and biopharmaceutical clients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on KRW BioReg Solutions.